Literature DB >> 21356374

Molecular mechanisms of bladder outlet obstruction in transgenic male mice overexpressing aromatase (Cyp19a1).

Wei Lin1, Nafis A Rahman, Jian Lin, Hua Zhang, Kemian Gou, Wanpeng Yu, Dahai Zhu, Ning Li, Ilpo Huhtaniemi, Xiangdong Li.   

Abstract

We investigated the etiology and molecular mechanisms of bladder outlet obstruction (BOO). Transgenic (Tg) male mice overexpressing aromatase (Cyp19a1) under the ubiquitin C promoter in the estrogen-susceptible C57Bl/6J genetic background (AROM+/6J) developed inguinal hernia by 2 months and severe BOO by 9 to 10 months, with 100% penetrance. These mice gradually developed uremia, renal failure, renal retention, and finally died. The BOO bladders were threefold larger than in age-matched wild-type (WT) males and were filled with urine on necropsy. Hypotrophic smooth muscle cells formed the thin detrusor urinae muscle, and collagen III accumulation contributed to the reduced compliance of the bladder. p-AKT and ERα expression were up-regulated and Pten expression was down-regulated in the BOO bladder urothelium. Expression of only ERα in the intradetrusor fibroblasts suggests a specific role of this estrogen receptor form in urothelial proliferation. Inactivation of Pten, which in turn activated the p-AKT pathway, was strictly related to the activation of the ERα pathway in the BOO bladders. Human relevance for these findings was provided by increased expression of p-AKT, PCNA, and ERα and decreased expression of PTEN in severe human BOO samples, compared with subnormal to mild samples. These findings clarify the involvement of estrogen excess and/or imbalance of the androgen/estrogen ratio in the molecular pathogenetic mechanisms of BOO and provide a novel lead into potential treatment strategies for BOO.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21356374      PMCID: PMC3070572          DOI: 10.1016/j.ajpath.2010.11.056

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  52 in total

1.  Beyond BRCA1 and BRCA2 wild-type breast and/or ovarian cancer families: germline mutations in TP53 and PTEN.

Authors:  A Blanco; B Graña; L Fachal; M Santamariña; J Cameselle-Teijeiro; C Ruíz-Ponte; A Carracedo; A Vega
Journal:  Clin Genet       Date:  2009-11-23       Impact factor: 4.438

2.  Effects of the aromatase inhibitor testolactone on human benign prostatic hyperplasia.

Authors:  H U Schweikert; U W Tunn
Journal:  Steroids       Date:  1987 Jul-Sep       Impact factor: 2.668

Review 3.  Declining gonadal function in elderly men.

Authors:  J M Kaufman; A Vermeulen
Journal:  Baillieres Clin Endocrinol Metab       Date:  1997-07

4.  Localization of oestrogen receptors alpha and beta in human testis.

Authors:  S Mäkinen; S Mäkelä; Z Weihua; M Warner; B Rosenlund; S Salmi; O Hovatta; J A Gustafsson
Journal:  Mol Hum Reprod       Date:  2001-06       Impact factor: 4.025

5.  Endocrine status in elderly men with lower urinary tract symptoms: correlation of age, hormonal status, and lower urinary tract function. The Prostate Study Group of the Austrian Society of Urology.

Authors:  G Schatzl; C Brössner; S Schmid; W Kugler; M Roehrich; T Treu; A Szalay; B Djavan; C P Schmidbauer; S Söregi; S Madersbacher
Journal:  Urology       Date:  2000-03       Impact factor: 2.649

6.  Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder.

Authors:  Debra E Irwin; Ian Milsom; Zoe Kopp; Paul Abrams; Walter Artibani; Sender Herschorn
Journal:  Eur Urol       Date:  2009-03-03       Impact factor: 20.096

7.  Treatment of lower urinary tract symptoms suggestive of benign prostatic obstruction in real life practice in France.

Authors:  G Vallancien; P Pariente
Journal:  Prostate Cancer Prostatic Dis       Date:  2001       Impact factor: 5.554

8.  Prostatic inflammation and obstructive voiding in the adult Noble rat: impact of the testosterone to estradiol ratio in serum.

Authors:  Jenni Bernoulli; Emrah Yatkin; Yvonne Konkol; Eva-Maria Talvitie; Risto Santti; Tomi Streng
Journal:  Prostate       Date:  2008-09-01       Impact factor: 4.104

Review 9.  Genetic modelling of the PTEN/AKT pathway in cancer research.

Authors:  Oliver Renner; Carmen Blanco-Aparicio; Amancio Carnero
Journal:  Clin Transl Oncol       Date:  2008-10       Impact factor: 3.405

Review 10.  [Androgen and estrogen metabolism in human benign prostatic hyperplasia (BPH)].

Authors:  M Krieg; H Weisser; S Tunn
Journal:  Verh Dtsch Ges Pathol       Date:  1993
View more
  11 in total

1.  Estrogen promotes Leydig cell engulfment by macrophages in male infertility.

Authors:  Wanpeng Yu; Han Zheng; Wei Lin; Astushi Tajima; Yong Zhang; Xiaoyan Zhang; Hongwen Zhang; Jihua Wu; Daishu Han; Nafis A Rahman; Kenneth S Korach; George Fu Gao; Ituro Inoue; Xiangdong Li
Journal:  J Clin Invest       Date:  2014-04-24       Impact factor: 14.808

2.  Urinary bladder organ hypertrophy is partially regulated by Akt1-mediated protein synthesis pathway.

Authors:  Li-Ya Qiao; Chunmei Xia; Shanwei Shen; Seong Ho Lee; Paul H Ratz; Matthew O Fraser; Amy Miner; John E Speich; Jeffrey J Lysiak; William D Steers
Journal:  Life Sci       Date:  2018-03-21       Impact factor: 5.037

3.  Characterization of miRNA-regulated networks, hubs of signaling, and biomarkers in obstruction-induced bladder dysfunction.

Authors:  Ali Hashemi Gheinani; Bernhard Kiss; Felix Moltzahn; Irene Keller; Rémy Bruggmann; Hubert Rehrauer; Catharine Aquino Fournier; Fiona C Burkhard; Katia Monastyrskaya
Journal:  JCI Insight       Date:  2017-01-26

4.  Morphology, sex steroid level and gene expression analysis in gonadal sex reversal of triploid female (XXX) rainbow trout (Oncorhynchus mykiss).

Authors:  Gefeng Xu; Tianqing Huang; Xian Jin; Cunhe Cui; Depeng Li; Cong Sun; Ying Han; Zhenbo Mu
Journal:  Fish Physiol Biochem       Date:  2015-09-15       Impact factor: 2.794

5.  Increased susceptibility of estrogen-induced bladder outlet obstruction in a novel mouse model.

Authors:  Neville Ngai-Chung Tam; Xiang Zhang; Hong Xiao; Dan Song; Linda Levin; Jarek Meller; Shuk-Mei Ho
Journal:  Lab Invest       Date:  2015-02-23       Impact factor: 5.662

Review 6.  Oestrogen action and male fertility: experimental and clinical findings.

Authors:  Xiangdong Li; Haiwen Li; Lina Jia; Xiru Li; Nafis Rahman
Journal:  Cell Mol Life Sci       Date:  2015-07-10       Impact factor: 9.261

Review 7.  Research Findings on Overactive Bladder.

Authors:  Phani B Patra; Sayani Patra
Journal:  Curr Urol       Date:  2015-05-20

8.  Estrogen receptor-α is a key mediator and therapeutic target for bladder complications of benign prostatic hyperplasia.

Authors:  Tristan M Nicholson; Michael A Moses; Kristen S Uchtmann; Kimberly P Keil; Dale E Bjorling; Chad M Vezina; Ronald W Wood; William A Ricke
Journal:  J Urol       Date:  2014-08-25       Impact factor: 7.450

9.  Chemoprevention of BBN-Induced Bladder Carcinogenesis by the Selective Estrogen Receptor Modulator Tamoxifen.

Authors:  Suraj Konnath George; Veronica Tovar-Sepulveda; Steven S Shen; Weiguo Jian; Yiqun Zhang; Susan G Hilsenbeck; Seth P Lerner; Carolyn L Smith
Journal:  Transl Oncol       Date:  2013-06-01       Impact factor: 4.243

10.  Maternal cypermethrin exposure during the perinatal period impairs testicular development in C57BL male offspring.

Authors:  Chaobin Huang; Xiangdong Li
Journal:  PLoS One       Date:  2014-05-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.